Gold Price News and Forecast: XAU/USD's outlook to remain downbeat in the coming sessions
|Gold Price Forecast: XAU/USD’s 4H chart signals caution amid stimulus hopes, ahead of Fed
Gold (XAU/USD) settled last week with modest losses below $1940, as the bears dominated amid fading hopes for a US coronavirus relief aid. Further, investors remained optimistic about the US Food and Drug Administration’s (FDA) authorization to Pfizer’s covid vaccine. Although the looming concerns over the virus growth on both sides of the Atlantic and no-deal Brexit fears cushioned the downside in the safe-haven gold.
The risk sentiment has improved starting out a fresh week, weighing on the yellow metal, as markets await the vaccine rollout in the US after the FDA authorization early Saturday. Further, renewed Brexit optimism after the talks extended past a Sunday deadline added to the upbeat market mood. Read more...
Gold: XAU/USD's outlook to remain downbeat in the coming sessions
Gold (XAU/USD) spots a potential descending triangle and bearish crossover as US stimulus and vaccine optimism down US dollar along with the yellow metal, FXStreet’s Dhwani Mehta reports.
“The vaccine optimism counters the likelihood of a US fiscal stimulus deal to be reached this week, rendering gold-negative. According to sources, a $908 billion bipartisan coronavirus relief package will be introduced in the US Congress as early as Monday. Also, gold traders remain jittery heading into the much-awaited and the final FOMC monetary policy decision of this year.” Read more...
Gold Price Analysis: XAU/USD flirts with session lows amid risk-on mood, downside seems limited
Gold edged lower through the early European session and refreshed daily lows, around the $1832 region in the last hour.
Following the previous session's two-way price moves, the precious metal witnessed some fresh selling on the first day of a new trading week and was pressured by the prevalent upbeat market mood. The global risk sentiment remained well supported by the optimism over the rollout of COVID-19 vaccines and got an additional boost from an extension of Brexit trade talks. Read more...
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.